Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0387320210310040472
Korean Journal of Health Policy and Administration
2021 Volume.31 No. 4 p.472 ~ p.478
The Severity of COVID-19 in Patients with Nonalcoholic Fatty Liver Disease in Korea
Park Hye-Ki

Joe Hyun
Abstract
Background: Early identification of patients who are highly likely to develop severe illness among confirmed cases of coronavirusdisease 19 (COVID-19) can be expected to lead to effective treatment. This study therefore aimed to determine whether thepresence of nonalcoholic fatty liver disease (NAFLD) has an impact on the exacerbation of COVID-19 symptoms.

Methods: The study used the Korean National Health Insurance claim data for treatment of COVID-19 patients in 2020. NAFLDincludes nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). The outcome variables used were hospitalizationand the use of medical devices. Hospitalization was defined by a length of stay exceeding one day and the use of medical deviceswas defined as one or more uses of a ventilator or extracorporeal membrane oxygenation. Multivariable logistic regression analysiswas performed to determine if there was a difference in the hospitalization and use of medical devices of COVID-19 patientsdepending on the presence of NAFLD.

Results: The odds ratio of hospitalization was 1.059, indicating slightly higher odds of hospitalization for patients with NAFL or NASHcompared to those without the conditions, but it was not statistically significant (0.969?1.156). On the other hand, the odds ratio ofuse of medical devices was high at 1.667 and was statistically significant (1.111?2.501).

Conclusion: The study results found NAFLD to be a risk factor that can exacerbate symptoms in COVID-19 patients. Accordingly, itis necessary to identify NAFLD patients through preemptive screening and provide them with appropriate treatments.
KEYWORD
COVID-19, Non-alcoholic fatty liver disease, Severity, Hospitalization, Equipment and supplies, Korea
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed